Your browser doesn't support javascript.
loading
Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.
Chojecki, Aleksander L; Arnall, Justin; Boselli, Danielle; Patel, Rushil; Chiad, Zane; DiSogra, Kristyn Y; Karabinos, Allison; Chen, Tommy; Cruz, Adilen; Verbyla, Allison; Ai, Jing; Knight, Thomas G; Ragon, Brittany K; Shah, Nilay A; Sanikommu, Srinivasa R; Symanowski, James; Avalos, Belinda R; Copelan, Edward A; Grunwald, Michael R.
Afiliación
  • Chojecki AL; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Electronic address: Aleksander.Chojecki@atriumhealth.org.
  • Arnall J; Atrium Health Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
  • Boselli D; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Patel R; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Chiad Z; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • DiSogra KY; Atrium Health Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
  • Karabinos A; Atrium Health Specialty Pharmacy Service, Atrium Health, Charlotte, NC, USA.
  • Chen T; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Cruz A; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Verbyla A; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Ai J; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Knight TG; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Ragon BK; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Shah NA; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Sanikommu SR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Symanowski J; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Avalos BR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Copelan EA; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Leuk Res ; 119: 106904, 2022 08.
Article en En | MEDLINE | ID: mdl-35753088
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Compuestos Bicíclicos Heterocíclicos con Puentes Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Compuestos Bicíclicos Heterocíclicos con Puentes Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article